MedicoLegal CV

Name: Stephen Peter Dobbs

Date of Birth: 2^nd May 1963

Email                           [email protected]

Secretary                     [email protected]

Medical Education

Undergraduate           Queen’s University of Belfast (1982-1987)

Postgraduate              Nottingham University Medical School (1995-1997)

Medical Qualifications

1987                MB BCh BAO (Belfast)

199?                MRCOG (London)

1999                DM (Nottingham)

200?                FRCOG (London)

DM thesis

Angiogenesis in Cervical Intraepithelial Neoplasia and cervical Cancer

Awarded Doctor of Medicine (University of Nottingham) December 1999

Medico-Legal Training

November 2020: Inspire MediLaw 2 day Expert Medical Witness course. Oxford

I have provided 12 medical reports in the past year.

Registration Details

General Medical Council registration: 3247963

Revalidated March 2019

Obstetrics and Gynaecology Specialist Register

CCST awarded October 1999

RCOG Sub specialist in Gynaecological Oncology

BSCCP accredited colposcopist

Current appointment

Consultant Gynaecological Oncologist

Belfast Trust

Belfast

Appointed 1^st November 1999

Societies

Royal College of Obstetricians and Gynaecologists (Fellow)

British Gynaecological Cancer Society (Council member 2018-present, chair of Professional Development Committee)

Irish Gynaecological Cancer society

European society of Gynaecological Cancer

British Society of colposcopy and Cervical Pathology (ex council member)

Gynaecological Travellers Club.

Immediate previous appointment

Senior Registrar/Sub Speciality trainee in Gynaecological Oncology. 

March 1997- September 1999           Leicester Royal Infirmary

Management Appointments Held

Chair Northern Ireland Gynaecological Oncology MDT (2015-2018)

Lead clinician for colposcopy services, Belfast Trust (2014-2017)

Lead clinician for Gynaecological Oncology, Belfast Trust (2017-2019)

Programme director for Sub speciality training in Gynaecological Oncology, Belfast Trust (2015-2019).

Gynaecological Oncology

Cervical Cancer

Ovarian Cancer

Endometrial Cancer

Vulval Cancer

Colposcopy

Cervical screening

Management of cervical intraepithelial neoplasia (CIN)

Management of Vulval intraepithelial neoplasia (VIN) and multifocal intraepithelial neoplasia (Mufin).

Gynaecology

Menorrhagia/Dysfunctional Uterine Bleeding

Management of fibroids

Laparoscopic surgery

Benign ovarian cysts

Medico-legal

Personal injury

Medical Negligence

Causation and Prognosis reports

Adviser to GMC Fitness to Practice panel

Adviser to IMC Fitness to Practice panel

Books and book chapters

Gynaecology by ten teachers 19^th Edition.  Edited by Ash Monga and Stephen Dobbs (2011) Hachette UK (Winner of BMJ book of the year 2012)

Vulval conditions, D Nunns and S Dobbs.  in Progress in Obstetrics and Gynaecology Vol 11

Peer reviewed papers

Second line treatment with ifosfamide and carboplatin in patients with ovarian cancer relapsing after treatment with carboplatin.  Dobbs SP, Gribbin C, Chan SY and Bessell EM. Eur J Cancer. (1994);30:30-33

A standardised breakfast tolerance test in pregnancy: comparison with the 75g oral glucose tolerance test in unselected mothers and in those with impaired glucose tolerance.  Roberts RN, McManus J, Dobbs SP, Hadden DR.  Ulster Med J. (1997);66:18-23

Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC.  Br J Cancer (1997);76:1410-5.

A prospective randomized trial comparing continuous bladder drainage with catheterization at abdominal hysterectomy. Dobbs SP et al.  Br J Urol. (1997);80:554-6.

Patient satisfaction with daycase laparoscopy. Dobbs SP, Davies Q, Hammond RH. J Obstet Gynaecol. (1998);18:471-3.

Borderline malignant change in recurrent mullerian papilloma of the vagina. Dobbs SP, shaw PA, Brown LJ, Ireland D. J Clin Pathol. (1998);51:875-7.

Surgical treatment of recurrent primary ovarian leiomyosarcoma. A case report.  Dobbs SP, Brown LJ, Hollingworth J, Ireland D. Eur J Gynaecol Oncol. (1999);20:172-3.

Cervical disease in women referred to colposcopy following inadequate smears.  Hollingworth J, Kotecha K, Dobbs SP, Ireland D.  Cytopathology.(2000);11:45-52.

Does histological incomplete excision of cervical intraepithelial neoplasia following large loop excision of transformation zone increase recurrence rates? A six year cytological follow up. Dobbs SP et al.  BJOG.(2000);107:1298-301.

Platelet derived endothelial cell growth factor expression and angiogenesis in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix. Dobbs SP et al. Ann Diagn Pathol. (2000);4:286-92.

Primary adenocarcinoma of the vagina arising in endocervicosis.  McGluggage WG, Price J, Dobbs SP. Int J Gynecol Path. (2001);20:399-402.

Morphological effects of chemotherapy on ovarian cancer. McCluggage WG….Dobbs SP et al.J Clin Pathol.(2002);55:27-31.

Extragenital mullerian carcinosarcoma arising from the peritoneum:report of two cases.Sumanthi VP, Murnaghan M, Dobbs SP, McCluggage WG.Int J Gynecol Cancer.(2002);12:764-7.

Soft tissue, pelvic and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma.  Venkatraman L,….Dobbs SP et al. J Clin Pathol. (2003);56:233-6.

Successful photodynamic therapy of vulval Paget’s disease using a novel patch based delivery system containing 5-aminolevulinic acid.  Zawislak A…..Dobbs SP et al. BJOG. (2004);11:1143-5.

The large loop excision of the transformation zone cut or blend thermal artefact study: a randomized controlled trial. Nagar H, Dobbs SP et al. Int J Gynaecol Cancer (2004);14:1108-11.

The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Nagar H, Dobbs SP et al. Gynecol Oncol.(2006);103:431-4.

Aggressive angiomxyomaof the vulva; Dramatic response to gonadotrophin-releasing hormone agonist therapy. Mccluggage WG, Jamison T, Dobbs SP, Grey A. Gynecol Oncol (2006);100:623-5.

The management of VIN in Northern Ireland.  Zawislak A, Price JP, Dobbs SP, McClelland HR, McCluggage WG.  Int J Gynecol Cancer. (2006);16:780-5.

Is laparoscopically assisted radical vaginal hysterectomy for cervical cancer safe? A case controlled study with follow up. Morgan DJ, Hunter DC, McCracken G, McClelland HR, Price JH, Dobbs SP (2007);114:537-42.

Doctor –when can I drive? Advice obstetricians and gynaecologists give on driving after obstetric or gynaecological surgery.  Kalkur S, McKenna D, Dobbs SP.  Ulster Med J. (2007)76:141-3.

Endometrial hyperplasia involving endometrial polyps:report of a series and discussion of the significance in an endometrial biopsy specimen.  Kelly P,Dobbs SP, McCluggage WG. BJOG. (2007);114:944-50.

An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma. Miller K, Price JH, Dobbs SP et al. J Clin Pathol. (2008):61:652-7.

Recruitment to multicentre trials – lessons from UKCTOCS:descriptive study. UKCTOCS group.  BMJ. (2008);337:2976.

Response of vulval lichen sclerosis and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system.  Zawislak A….Dobbs SP et al. Photodermatol Photoimmunol Photomed. (2009);25:111-3.

Cervical adenocarcinoma in situ recurring as vaginal adenocarcinoma 16 years after hysterectomy.  Hurrell DP, Jamison J, Dobbs SP, McCluggage WG.  Int J Gynecol Pathol. (2009);28:296-300.

Efficacy of systematic pelvic lymphadenopathy in endometrial cancer (MRC ASTEC trial): a randomised study. ASTEC study group. Lancet (2009)373:125-36.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative trial of Ovarian Cancer Screening (UKCTOCS). UKCTOCS study group. Lancet Oncol. (2009)10:327-40.

Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid.  Zawislak A….Dobbs S et al. Photodiagnosis Photodyn Ther. (2009);6:28-40.

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening:baseline survey of 21,715 women participating in the UK  Collaborative Trial of Ovarian Cancer screeing.  UKCTOCS trial group. Br J Cancer (2010);103:454-61.

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.  UKCTOCS Trial Group.  Lancet Oncol. (2011);12:38-48.

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials.  UKCTOCS Trial Group. Trials (2011);1:12-61.

Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective study.  UKCTOCS Trial Group(2012);BJOG:119:207-19.

Diagnostic accuracy of magnetic resonance imaging in endometrial cancer.  McComiskey MH, McCluggage WG, Grey A, Harley I, Dobbs S, Nagar HA.  Int J Gynecol Cancer (2012);22:1020-5.

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound –detected ovarian masses:a prospective cohort study within the UK Collaborative trial of Ovarian Cancer Screening (UKCTOCS). UKCTOCS Trial Group.  Ultrasound Obstet Gynecol.  (2012);40:338-44.

Aetefactual displacement of cervical epithelium showing CIN III to fallopian tubes during laparoscopic hysterectomy with intrauterine balloon manipulator.  Mcfarland M, Craig E, Lioe TF, Dobbs SP, McCluggage WG.  Histopathology (2014);65: 139-141.

Epidermal growth factor receptor (EGFR). HER2 and insulin-like growth factor -1 receptor (IGF-1R) staus in ovarian adult granulosa cell tumours.  Higgins PA, Brady A, Dobbs SP et al Histopathology. (2014) 64: 633-638/

Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.  UKCTOCS trial group.  J Clin Oncol (2015) 33: 2062-2071.

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised , controlled, non-inferiority trial. Kehoe S, Hook J, Nankivell et al Lancet (2015);386: 249-257.

Ovarian Cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening 9UKCTOCS): a randomised controlled trial.  UKCTOCS trial group.  Lancet (2016) 387: 945-956.

The cost effectiveness of screening for ovarian cancer: results from the UK collaborative Trial of Ovarian Cancer Screening (UKCTOCS).  UKCTOCS trial group. Br J Cancer (2017) 117:619-627.

Early catheter removal following laparoscopic radical hysterectomy for cervical cancer: assessment of a new bladder care protocol.  J Obstet Gynaecol. (2017) 37: 970-972.

Neodajuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual analysis of individual patient data from the EORTC 55971 and CHORUS trials EORTC/CHORUS study investigators.  Lancet Oncol (2018) 19: 1680-1687.

Survival of women with early stage cervical cancer in the UK treated with minimal access and open surgery.  Martin-Hirsch P, Wood N Whitham NL et al BJOG (2019) 126: 956-959.

Sentinel lymph node consensus document of the British Gynaecological Cancer Society for endometrial, vulvar and cervical cancers.  Fotopoluou C, Ind T, Baldwin P et al  Int J Gynecol Cancer. (2019) 29:1348-1350.